ASX - By Stock
|
1AD |
Re:
Ann: Institutional investment to pursue strategic initiatives
|
|
akathaddeus
|
25 |
5.3K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
25
|
5.3K
|
7
|
|
ASX - By Stock
|
SYA |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
akathaddeus
|
262 |
95K |
24 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
262
|
95K
|
24
|
|
ASX - By Stock
|
IBX |
Re:
Well this share price is embarrassing !
|
|
akathaddeus
|
57 |
23K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
57
|
23K
|
4
|
|
ASX - By Stock
|
SYA |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
akathaddeus
|
229 |
93K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
229
|
93K
|
0
|
|
ASX - By Stock
|
SYA |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
akathaddeus
|
229 |
93K |
8 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
229
|
93K
|
8
|
|
ASX - By Stock
|
SYA |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
akathaddeus
|
229 |
93K |
12 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
229
|
93K
|
12
|
|
ASX - By Stock
|
RWD |
Re:
Ann: Letter to Eligible Shareholders
|
|
akathaddeus
|
8 |
2.5K |
6 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
8
|
2.5K
|
6
|
|
ASX - By Stock
|
SYA |
Re:
Ann: First Lithium Shipment Boosts NAL Revenues
|
|
akathaddeus
|
348 |
134K |
37 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
348
|
134K
|
37
|
|
ASX - By Stock
|
SYA |
Re:
Ann: Board of Director Changes
|
|
akathaddeus
|
526 |
239K |
57 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
526
|
239K
|
57
|
|
ASX - By Stock
|
PER |
Re:
Gill Price delivered at 2023 PPMD Conference
|
|
akathaddeus
|
23 |
7.8K |
4 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
23
|
7.8K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
1 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
74
|
29K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
6 |
11/06/23 |
11/06/23 |
ASX - By Stock
|
74
|
29K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
4 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
74
|
29K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
7 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
74
|
29K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
2 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
74
|
29K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
0 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
74
|
29K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
4 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
74
|
29K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
3 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
74
|
29K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
7 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
74
|
29K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion initiates leadership restructuring plan
|
|
akathaddeus
|
74 |
29K |
9 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
74
|
29K
|
9
|
|
ASX - By Stock
|
1AD |
Re:
Ann: 1AD & GPCR Therapeutics to evaluate CXCR4 i-bodies in cancer
|
|
akathaddeus
|
10 |
3.5K |
1 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
10
|
3.5K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
IBXOA Option Holders / Rights Issue / Funding by Mercer
|
|
akathaddeus
|
7 |
4.2K |
8 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
7
|
4.2K
|
8
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
akathaddeus
|
2 |
1.1K |
4 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
2
|
1.1K
|
4
|
|
ASX - By Stock
|
OBM |
Re:
Ann: Riverina Exploration Update
|
|
akathaddeus
|
3 |
1.6K |
5 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
3
|
1.6K
|
5
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
akathaddeus
|
138K |
52M |
9 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
138K
|
52M
|
9
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
akathaddeus
|
138K |
52M |
34 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
138K
|
52M
|
34
|
|
ASX - By Stock
|
OBM |
Re:
Ann: OBM Strategy & Values Presentation - August 2022
|
|
akathaddeus
|
69 |
28K |
5 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
69
|
28K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Notice of Allowance for Cynata US Patent
|
|
akathaddeus
|
1 |
900 |
17 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
1
|
900
|
17
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX unveils new clinic-ready CAR-T enhancement platform
|
|
akathaddeus
|
101 |
43K |
4 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
101
|
43K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
akathaddeus
|
605 |
226K |
13 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
605
|
226K
|
13
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
akathaddeus
|
605 |
226K |
7 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
605
|
226K
|
7
|
|
ASX - By Stock
|
OBM |
Re:
Ann: Operational Update
|
|
akathaddeus
|
108 |
46K |
1 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
108
|
46K
|
1
|
|
ASX - By Stock
|
OBM |
Re:
Ann: Operational Update
|
|
akathaddeus
|
108 |
46K |
0 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
108
|
46K
|
0
|
|
ASX - By Stock
|
OBM |
Re:
Ann: Operational Update
|
|
akathaddeus
|
108 |
46K |
0 |
15/05/22 |
15/05/22 |
ASX - By Stock
|
108
|
46K
|
0
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Update on Development Program with BASF
|
|
akathaddeus
|
117 |
32K |
7 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
117
|
32K
|
7
|
|
ASX - By Stock
|
BGT Biotech |
Re:
BioGene Media
|
|
akathaddeus
|
102 |
34K |
9 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
102
|
34K
|
9
|
|
ASX - By Stock
|
KLL |
Re:
Ann: Appointment of Chief Executive Officer
|
|
akathaddeus
|
131 |
46K |
0 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
131
|
46K
|
0
|
|
ASX - By Stock
|
KLL |
Re:
Ann: Appointment of Chief Executive Officer
|
|
akathaddeus
|
131 |
46K |
5 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
131
|
46K
|
5
|
|
ASX - By Stock
|
OBM |
Re:
OBM Performance JAN 2022 - MAR 2022 (3Q)
|
|
akathaddeus
|
23 |
4.8K |
3 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
23
|
4.8K
|
3
|
|
ASX - By Stock
|
OBM |
Re:
OBM Performance JAN 2022 - MAR 2022 (3Q)
|
|
akathaddeus
|
23 |
4.8K |
9 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
23
|
4.8K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Biosystems December 2021 Investor Newsletter
|
|
akathaddeus
|
65 |
20K |
19 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
65
|
20K
|
19
|
|
ASX - By Stock
|
OBM |
Re:
Production update
|
|
akathaddeus
|
12 |
4.7K |
1 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
12
|
4.7K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Ptx to 10 bag by this time next year
|
|
akathaddeus
|
840 |
320K |
3 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
840
|
320K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Ptx to 10 bag by this time next year
|
|
akathaddeus
|
840 |
320K |
2 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
840
|
320K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Ptx to 10 bag by this time next year
|
|
akathaddeus
|
840 |
320K |
0 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
840
|
320K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Ptx to 10 bag by this time next year
|
|
akathaddeus
|
840 |
320K |
5 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
840
|
320K
|
5
|
|
ASX - By Stock
|
PTX |
Re:
Ptx to 10 bag by this time next year
|
|
akathaddeus
|
840 |
320K |
1 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
840
|
320K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Ptx to 10 bag by this time next year
|
|
akathaddeus
|
840 |
320K |
15 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
840
|
320K
|
15
|
|
ASX - By Stock
|
PTX |
Re:
Ptx to 10 bag by this time next year
|
|
akathaddeus
|
840 |
320K |
8 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
840
|
320K
|
8
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
akathaddeus
|
2.1K |
629K |
18 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
2.1K
|
629K
|
18
|
|